Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature

BACKGROUND: WHO’s Global Programme to Eliminate Lymphatic Filariasis (LF) uses mass drug administration (MDA) of anthelmintic medications to interrupt LF transmission in endemic areas. Recently, a single dose combination of ivermectin (IVM), diethylcarbamazine (DEC), and albendazole (ALB) was shown...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS Negl Trop Dis
Main Authors: Budge, Philip J., Herbert, Carly, Andersen, Britt J., Weil, Gary J.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5973625/
https://ncbi.nlm.nih.gov/pubmed/29768412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0006454
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares